AI assistant
Sending…
Synergy CHC Corp. — Director's Dealing 2015
Nov 16, 2015
34910_dirs_2015-11-16_ab15a3da-3e37-429f-9d8a-740ce79bbb4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Synergy CHC Corp. (SNYR)
CIK: 0001562733
Period of Report: 2015-11-12
Reporting Person: Knight Therapeutics (Barbados) Inc. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-12 | Common Stock | J | 5550625 | — | Acquired | 10145812 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-12 | Warrants | $0.49 | J | 1 | Acquired | 2025-11-12 | Common Shares (4547243) | Direct |
Footnotes
F1: The shares of common stock were acquired upon the exercise of a warrant issued to the Reporting Person on November 12, 2015 for $1.00.
F2: The warrants were acquired by the Reporting Person in conjunction with the issuance of a debenture by the Reporting Person to the Issuer.
More from Synergy CHC Corp.
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 3
Regulatory Filings
2025
Dec 10